| Autor: |
Meyers G; Department of Medicine, Oregon Health and Science University, Knight Cancer Institute, Portland, OR, USA. meyersg@ohsu.edu., Hamadani M; BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA., Martens M; Medical College of Wisconsin, Milwaukee, WI, USA., Ali H; Division of Leukemia, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical, Duarte, CA, USA., Choe H; Division of Hematology, The Ohio State University Comprehensive Cancer Center-James, Columbus, OH, USA., Dawson P; The Emmes Company, Rockville, MD, USA., Harris AC; MSK Kids Stem Cell Transplantation and Cellular Therapies, Memorial Sloan Kettering Cancer Center, New York, NY, USA., van Hooren E; Xenikos BV, Nijmegen, The Netherlands., Klaassen W; Xenikos BV, Nijmegen, The Netherlands., Leifer E; National Heart, Lung, and Blood Institute, Bethesda, MD, USA., MacMillan ML; Blood and Marrow Transplantation & Cellular Therapy Program, Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA., van Oosterhout Y; Xenikos BV, Nijmegen, The Netherlands., Perez L; H. Lee Moffitt Cancer Center, Tampa, FL, USA., Pusic I; Division of Oncology, BMT and Leukemia Section, Washington University School of Medicine, St. Louis, MO, USA., Vo P; Clinical Research Division, Fred Hutchinson Cancer Research Center, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA., Levine JE; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. |
Full text from SpringerLink